ESRRB and breast carcinoma: Our clustering analysis does nevertheless identify the orphan nuclear receptor TLX as an important variable in breast cancer, which is preferentially expressed in ERα-negative breast cancer where its importance is indicated by the prognostic significance of its expression and siRNA mediated growth inhibition and EMT.